<DOC>
	<DOCNO>NCT02992080</DOCNO>
	<brief_summary>The aim study ass miRNAs expression profile circuling blood patient cystic fibrosis highlight `` signature '' could reflect pulmonary status patient</brief_summary>
	<brief_title>Small Circulating RNA Molecular Markers Lung Disease Cystic Fibrosis</brief_title>
	<detailed_description>The objective project study circulate miRNA profile 40 patient cystic fibrosis 40 healthy individual ass whether biomolecules could use marker pulmonary disease cystic fifbosis . Moreover compare miRNAs expression level Cystic fibrosis ( CF ) patient severe ( n=20 ) moderate ( n=20 ) pulmonary impairment , want ass whether miRNAs may use marker severity CF pulmonary disease . The identification sensitive early marker , non-invasive sampling could enable effective early treatment CF patient</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Patients Cystic fibrosis ( CF ) ( MIM # 219700 ) compound heterozygous homozygous CF cause mutation Healthy control non smoker free pulmonary disease Participation within exclusion period clinicals trial Patients carry mutation clinical vary consequence non CFcausing mutation smoker</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Patient Cystic Fibrosis</keyword>
	<keyword>Patient without Cystic fibrosis</keyword>
</DOC>